Vaccitech plc - ADR

+0.30 (+7.50%)
Earnings Announcements

Vaccitech Reports Full-Year 2021 Financial Results And Recent Corporate Developments

Published: 03/25/2022 11:25 GMT
Vaccitech plc - ADR (VACC) - Vaccitech Reports Full-year 2021 Financial Results and Recent Corporate Developments.
Vaccitech Plc - As of December 31, 2021, Cash and Cash Equivalents Were $214.1 Million, Compared to $43.3 Million As of December 31, 2020.
Vaccitech Plc - Company Believes Its Cash and Cash Equivalents Are Sufficient to Fund Operations Into Second Half of 2024.
Revenue is expected to be $3.7 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $4.37 Million
Next Quarter EPS Guidance is expected to be -$0.43

More details on our Analysts Page.